JAZZ Iron Condor Strategy
JAZZ (Jazz Pharmaceuticals plc), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Modeyso for the treatment of diffuse midline glioma harboring an H3 K27M mutation; and Defitelio to treat severe veno-occlusive disease. It also develops Zanidatamab in Phase 3 trial to treat HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC); Dordaviprone to treat H3 K27M-mutant diffuse glioma; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. In addition, the company is developing Zanidatamab to treat neoadjuvant and adjuvant breast cancer; Vyxeos for the treatment of High-risk MDS, newly diagnosed untreated patients with high-risk AML, and De novo intermediate or adverse risk AML stratified by genomics; and JZP3507 to treat pheochromocytoma and paraganglioma that are in Phase 2 clinical trials. Further, it develops JZP815 to treat Raf and Ras mutant tumors; JZP898 for the IFN INDUKIN molecule in solid tumors; and JZP047 to treat absence epilepsy that are in Phase 1 clinical trials. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc.
JAZZ (Jazz Pharmaceuticals plc) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $14.45B, a trailing P/E of 482.77, a beta of 0.33 versus the broader market, a 52-week range of 105-243.32, average daily share volume of 934K, a public-listing history dating back to 2007, approximately 3K full-time employees. These structural characteristics shape how JAZZ stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.33 indicates JAZZ has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 482.77 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a iron condor on JAZZ?
An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.
Current JAZZ snapshot
As of June 30, 2026, spot at $241.18, ATM IV 33.30%, IV rank 13.36%, expected move 9.55%. The iron condor on JAZZ below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this iron condor structure on JAZZ specifically: JAZZ IV at 33.30% is on the cheap side of its 1-year range, which means a premium-selling JAZZ iron condor collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 9.55% (roughly $23.02 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated JAZZ expiries trade a higher absolute premium for lower per-day decay. Position sizing on JAZZ should anchor to the underlying notional of $241.18 per share and to the trader's directional view on JAZZ stock.
JAZZ iron condor setup
The JAZZ iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With JAZZ near $241.18, the first option leg uses a $250.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed JAZZ chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 JAZZ shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Call | $250.00 | $3.15 |
| Buy 1 | Call | $270.00 | $0.25 |
| Sell 1 | Put | $230.00 | $3.45 |
| Buy 1 | Put | $220.00 | $2.00 |
JAZZ iron condor risk and reward
- Net Premium / Debit
- +$435.00
- Max Profit (per contract)
- $435.00
- Max Loss (per contract)
- -$1,565.00
- Breakeven(s)
- $225.65, $254.35
- Risk / Reward Ratio
- 0.278
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.
JAZZ iron condor payoff curve
Modeled P&L at expiration across a range of underlying prices for the iron condor on JAZZ. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$565.00 |
| $53.34 | -77.9% | -$565.00 |
| $106.66 | -55.8% | -$565.00 |
| $159.99 | -33.7% | -$565.00 |
| $213.31 | -11.6% | -$565.00 |
| $266.64 | +10.6% | -$1,228.56 |
| $319.96 | +32.7% | -$1,565.00 |
| $373.29 | +54.8% | -$1,565.00 |
| $426.61 | +76.9% | -$1,565.00 |
| $479.94 | +99.0% | -$1,565.00 |
When traders use iron condor on JAZZ
Iron condors on JAZZ are a delta-neutral premium-collection structure that profits if JAZZ stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
JAZZ thesis for this iron condor
The market-implied 1-standard-deviation range for JAZZ extends from approximately $218.16 on the downside to $264.20 on the upside. A JAZZ iron condor is a delta-neutral premium-collection structure that pays off when JAZZ stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current JAZZ IV rank near 13.36% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on JAZZ at 33.30%. As a Healthcare name, JAZZ options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to JAZZ-specific events.
JAZZ iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. JAZZ positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move JAZZ alongside the broader basket even when JAZZ-specific fundamentals are unchanged. Short-premium structures like a iron condor on JAZZ carry tail risk when realized volatility exceeds the implied move; review historical JAZZ earnings reactions and macro stress periods before sizing. Always rebuild the position from current JAZZ chain quotes before placing a trade.
Frequently asked questions
- What is a iron condor on JAZZ?
- A iron condor on JAZZ is the iron condor strategy applied to JAZZ (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With JAZZ stock trading near $241.18, the strikes shown on this page are snapped to the nearest listed JAZZ chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are JAZZ iron condor max profit and max loss calculated?
- Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the JAZZ iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 33.30%), the computed maximum profit is $435.00 per contract and the computed maximum loss is -$1,565.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a JAZZ iron condor?
- The breakeven for the JAZZ iron condor priced on this page is roughly $225.65 and $254.35 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current JAZZ market-implied 1-standard-deviation expected move is approximately 9.55%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a iron condor on JAZZ?
- Iron condors on JAZZ are a delta-neutral premium-collection structure that profits if JAZZ stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
- How does current JAZZ implied volatility affect this iron condor?
- JAZZ ATM IV is at 33.30% with IV rank near 13.36%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.